Impact of an integrated medicines management service on preventable medicines-related readmission to hospital: a descriptive study

Eur J Hosp Pharm. 2017 Nov;24(6):327-331. doi: 10.1136/ejhpharm-2016-000984. Epub 2016 Nov 1.

Abstract

Background: Medication contributes to 5-20% of hospital admissions, of which half are considered preventable. An integrated medicines management service (IMMS) was developed at a large general hospital in London to identify and manage patients at risk of a preventable medicines-related readmission (PMRR) to reduce the risk of PMRR.

Objective: To investigate the effect of the pharmacy IMMS on the rate of PMRR within 30 days of the first discharge.

Method: 744 patients were identified between October 2008 and October 2014, using the PREVENT tool. Patients at risk were managed by the IMMS with medication reconciliation, review, consultation and follow-up, as required.

Results: Of 744 patients, 119 were readmitted within 30 days of discharge, with a PMRR for 2 patients (1.7%). The main reason for referral to the service was to assess the need to start a compliance aid. Most interventions involved communication: 84% included patient consultations with 50% involving discussion with the patient's community pharmacist and 32% with their general practitioner surgery.

Conclusions: An IMMS may be an effective method of reducing the rate of PMRR. Further work is needed to establish the cost-effectiveness of the service.

Keywords: discharge planning; medicine safety; medicines optimisation; pharmacy interventions; readmissions.